We are live on ! Find out more
AZR icon

Azora Therapeutics

22 hedge funds and large institutions have $2.81M invested in Azora Therapeutics in 2026 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,233% more capital inflows, than outflows

Capital inflows: $2.58M | Capital outflows: $111K

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

29% more funds holding

Funds holding: 17 → 22 (+5)

20.3% more ownership

Funds ownership: 6.37% → 26.67% (+20%)

Holders
22
Holders Change
+5
Holders Change %
+29.41%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
7
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

AZR Hedge Fund Activity: Q3 2026 in Review

22 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Azora Therapeutics (AZR) for Q3 2026, worth a combined $2.81M — up 740% from $335K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new AZR positions and 2 closed out — a net gain of 5 holders — while 7 added to existing stakes and 2 trimmed.

The largest buyer was KVP Capital Advisors, opening a new position worth an estimated $904K. The largest seller was UBS Group, cutting an estimated $75.1K.

  • 22 institutional investors held Azora Therapeutics (AZR) as of Q3 2026, up from 17 in Q2 2026.
  • Funds reported $2.81M of Azora Therapeutics stock for Q3 2026, up 740% quarter-over-quarter.
  • 7 funds opened new Azora Therapeutics positions in Q3 2026 and 2 closed out, a net change of +5 holders.
  • The largest Azora Therapeutics buyer in Q3 2026 was KVP Capital Advisors, an estimated $904K added.
  • The largest Azora Therapeutics seller in Q3 2026 was UBS Group, an estimated $75.1K sold.

Based on aggregated 13F filings for Q3 2026.